Today, the Pres. Americas of Resmed Inc (RMD), James Hollingshead, sold shares of RMD for $621.8K.
Following James Hollingshead’s last RMD Sell transaction on November 22, 2017, the stock climbed by 21.2%. In addition to James Hollingshead, 3 other RMD executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Resmed Inc’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $588 million and quarterly net profit of $106 million. In comparison, last year the company earned revenue of $524 million and had a net profit of $86.13 million. RMD’s market cap is $14.92B and the company has a P/E ratio of 45.51. Currently, Resmed Inc has an average volume of 829.9K.
Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $94.50, reflecting a -10.5% downside.
In the last 30 days, insiders have sold $1.4M worth of RMD shares and purchased $144.3K worth of RMD shares. The insider sentiment on Resmed Inc has been neutral according to 110 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
